NORTH CHICAGO, Ill., Nov. 15, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Evercore ISI Biopharma Catalyst/DeepDive Conference on Wednesday, November 29, 2017. Bill Chase, executive vice president and chief financial officer, will present at 7 a.m. Central time.
About AbbVieAbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-2017-biopharma-catalystdeep-dive-conference-300555018.html
Subscribe to our Free Newsletters!
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...
Health insurance has emerged one of the fastest growing segments in the non-life insurance industry ...
Strabismus or squint is a failure of the two eyes to maintain proper alignment when looking at an ...View All